{"DataElement":{"publicId":"5118565","version":"1","preferredName":"Lymphoma Clinical and Pathologic Ann Arbor System Stage","preferredDefinition":"Text term that represents the clinical or pathologic stage for lymphoma using the Ann Arbor Lymphoma Staging System.","longName":"5118553v1.0:5118556v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"5118553","version":"1","preferredName":"Lymphoma Clinical Pathologic Ann Arbor Lymphoma Staging System","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Caused by or altered by or manifesting disease or pathology._The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","longName":"2475110v1.0:5118551v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2475110","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11901624-1EB2-3055-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-16","modifiedBy":"ONEDATA","dateModified":"2006-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5118551","version":"1","preferredName":"Clinical Pathologic Ann Arbor Lymphoma Staging System","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Caused by or altered by or manifesting disease or pathology.:The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","longName":"C25398:C25610:C54179","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ann Arbor Lymphoma Staging System","conceptCode":"C54179","definition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5CE4C-48B9-8D3F-E050-BB89AD431BCD","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5CE4C-48CA-8D3F-E050-BB89AD431BCD","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CDDP CDF form per request by K.Wildermuth. mc 2/3/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5118556","version":"1","preferredName":"Ann Arbor Clinical and Pathologic Stage","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5118556v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Clinical Stage I","valueDescription":"Ann Arbor Clinical Stage I","ValueMeaning":{"publicId":"5118557","version":"1","preferredName":"Ann Arbor Clinical Stage I","longName":"5118557","preferredDefinition":"A clinical stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage I","conceptCode":"C125472","definition":"A clinical stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8CFB-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8D14-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Clinical Stage II","valueDescription":"Ann Arbor Clinical Stage II","ValueMeaning":{"publicId":"5118558","version":"1","preferredName":"Ann Arbor Clinical Stage II","longName":"5118558","preferredDefinition":"A clinical stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage II","conceptCode":"C125474","definition":"A clinical stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D20-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8D39-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Clinical Stage III","valueDescription":"Ann Arbor Clinical Stage III","ValueMeaning":{"publicId":"5118559","version":"1","preferredName":"Ann Arbor Clinical Stage III","longName":"5118559","preferredDefinition":"A clinical stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage III","conceptCode":"C125476","definition":"A clinical stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D45-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8D5E-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Pathologic Stage I","valueDescription":"Ann Arbor Pathologic Stage I","ValueMeaning":{"publicId":"5118560","version":"1","preferredName":"Ann Arbor Pathologic Stage I","longName":"5118560","preferredDefinition":"A pathologic stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Pathologic Stage I","conceptCode":"C125473","definition":"A pathologic stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D6A-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8D83-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Pathologic Stage II","valueDescription":"Ann Arbor Pathologic Stage II","ValueMeaning":{"publicId":"5118561","version":"1","preferredName":"Ann Arbor Pathologic Stage II","longName":"5118561","preferredDefinition":"A pathologic stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Pathologic Stage II","conceptCode":"C125475","definition":"A pathologic stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D8F-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8DA8-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Pathologic Stage III","valueDescription":"Ann Arbor Pathologic Stage III","ValueMeaning":{"publicId":"5118562","version":"1","preferredName":"Ann Arbor Pathologic Stage III","longName":"5118562","preferredDefinition":"A pathologic stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Pathologic Stage III","conceptCode":"C125477","definition":"A pathologic stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8DB4-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8DCD-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Clinical Stage IV","valueDescription":"Ann Arbor Clinical Stage IV","ValueMeaning":{"publicId":"5118563","version":"1","preferredName":"Ann Arbor Clinical Stage IV","longName":"5118563","preferredDefinition":"A clinical stage that refers to diffuse extralymphatic involvement by lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage IV","conceptCode":"C125478","definition":"A clinical stage that refers to diffuse extralymphatic involvement by lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8DD9-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8DF2-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"Pathologic Stage IV","valueDescription":"Ann Arbor Pathologic Stage IV","ValueMeaning":{"publicId":"5118564","version":"1","preferredName":"Ann Arbor Pathologic Stage IV","longName":"5118564","preferredDefinition":"A pathologic stage that refers to diffuse extralymphatic involvement by lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Pathologic Stage IV","conceptCode":"C125479","definition":"A pathologic stage that refers to diffuse extralymphatic involvement by lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8DFE-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE5E9B0-8E17-D3CC-E050-BB89AD4301C1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8CE2-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-29","changeDescription":"Created for CDDP CDF per request by K.Wildermuth. mc 2/3/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Ann Arbor Staging System: Tum","type":"Preferred Question Text","description":"Ann Arbor Staging System: Tumor Stage","url":null,"context":"NCIP"}],"origin":"CTSP/CDDP: Clinical Trial Sequencing and Cancer Driver Discovery Projects","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8E27-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"COOPERM","dateModified":"2016-10-03","changeDescription":"Created for CDDP CDF per request by K.Wildermuth. mc 2/3/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}